PACB News and Press, Pacific Biosciences of California Inc. From 06/26/23

2023-06-26 10:19:36 ET Pacific Biosciences of California ( NASDAQ: PACB ) entered into a privately negotiated exchange agreement with a certain noteholder, the company said Monday. Under the exchange agreement, PacBio will issue $441 million of its 1.375% convertible s...

PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030 PR Newswire MENLO PARK, Calif. , June 26, 2023 /PRNewswire/ -- Pacific Biosciences of California , Inc. (" PacBio ...

PacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research PR Newswire Collaboration Aims to Show Utility and Cost Effectiveness of HiFi Sequencing in Clinical Research Settings, Using Revio Systems MENLO PARK, Calif. , ...

PacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board PR Newswire Current Member, Jay Shendure , is Appointed Chair MENLO PARK, Calif. , May 30, 2023 /PRNewswire/ -- PacBio (NASDAQ: PAC...

2023-05-05 13:20:00 ET Summary I do not think our banking crisis is over. Much of this centers on the Fed raising rates too far and too fast, which is causing all kinds of havoc, especially our community and regional banks. All the members of the KBW Bank Index, including some of ...

PacBio to Present at BofA Securities 2023 Health Care Conference PR Newswire MENLO PARK, Calif. , May 3, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be partici...

2023-05-02 21:25:06 ET Pacific Biosciences of California, Inc. (PACB) Q1 2023 Earnings Conference Call May 02, 2023, 4:30 PM ET Company Participants Todd Friedman - Director, Investor Relations Christian Henry - President and Chief Executive Officer Susan Kim - C...

2023-05-02 16:03:31 ET Pacific Biosciences of California press release ( NASDAQ: PACB ): Q1 GAAP EPS of -$0.36 misses by $0.03 . Revenue of $38.9M (+17.3% Y/Y) beats by $4.52M . For further details see: Pacific Biosciences of California GAAP EPS of -$0.36...

PacBio Announces Record Revenue in First Quarter 2023 PR Newswire MENLO PARK, Calif. , May 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2023 . First quarter results R...

2023-04-21 18:34:12 ET Summary Pacific Biosciences of California, Inc.'s Revio long-read sequencing system is poised to enable large-scale research projects with increased efficiency. The commercial launch of the Revio platform, alongside the ongoing beta testing of the Onso bench...